Compare COGT & MAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COGT | MAT |
|---|---|---|
| Founded | 2014 | 1945 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 6.5B |
| IPO Year | 2018 | N/A |
| Metric | COGT | MAT |
|---|---|---|
| Price | $36.44 | $16.48 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 9 |
| Target Price | ★ $32.08 | $20.75 |
| AVG Volume (30 Days) | 1.8M | ★ 6.1M |
| Earning Date | 02-27-2026 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.24 |
| Revenue | N/A | ★ $5,347,600,000.00 |
| Revenue This Year | N/A | $6.25 |
| Revenue Next Year | N/A | $2.27 |
| P/E Ratio | ★ N/A | $13.28 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.72 | $13.95 |
| 52 Week High | $43.73 | $22.48 |
| Indicator | COGT | MAT |
|---|---|---|
| Relative Strength Index (RSI) | 49.13 | 28.40 |
| Support Level | $35.50 | $14.75 |
| Resistance Level | $38.19 | $22.48 |
| Average True Range (ATR) | 1.70 | 0.73 |
| MACD | -0.11 | -0.59 |
| Stochastic Oscillator | 38.19 | 23.53 |
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
Mattel manufactures and markets toy products that are sold to its wholesale and direct to retail customers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, hand-held and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Nearly 60% of its net sales were generated from North America in 2024, with the remainder stemming from international markets.